Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-3

• Published in: Journal of Immunology Vol. 179; no. 6; pp. 3622 - 3630
• Main Authors: Whitmore, Mark M, Iparraguirre, Amaya, Kubelka, Lindsey, Weninger, Wolfgang, Hai, Tsonwin, Williams, Bryan R. G
• Format: Journal Article
• Language: English
• Published: United States Am Assoc Immnol 15.09.2007
• Subjects: Activating Transcription Factor 3 - deficiency; Activating Transcription Factor 3 - genetics; Activating Transcription Factor 3 - physiology; Animals; Base Sequence; Cell Line; Dendritic Cells - immunology; Dendritic Cells - metabolism; Down-Regulation - genetics; Down-Regulation - immunology; Humans; Influenza virus; Interleukin-12 Subunit p40 - antagonists & inhibitors; Interleukin-12 Subunit p40 - genetics; Macrophages, Peritoneal - immunology; Macrophages, Peritoneal - metabolism; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Orthomyxoviridae Infections - genetics; Orthomyxoviridae Infections - immunology; Promoter Regions, Genetic - immunology; Repressor Proteins - genetics; Repressor Proteins - physiology; Sequence Deletion; Signal Transduction - genetics; Signal Transduction - immunology; Toll-Like Receptors - antagonists & inhibitors; Toll-Like Receptors - physiology
• ISSN: 0022-1767; 1550-6606; 1365-2567
• DOI: 10.4049/jimmunol.179.6.3622

Activating transcription factor-3 (ATF3) is rapidly induced by LPS in mouse macrophages and regulates TLR4 responses. We show that ATF3 is rapidly induced by various TLRs in mouse macrophages and plasmacytoid dendritic cells (DCs), as well as plasmacytoid and myeloid subsets of human DCs. In primary macrophages from mice with a targeted deletion of the atf3 gene (ATF3-knockout (KO)), TLR-stimulated levels of IL-12 and IL-6 were elevated relative to responses in wild-type macrophages. Similarly, targeted deletion of atf3 correlated with enhanced responsiveness of myeloid DCs to TLR activation as measured by IL-12 secretion. Ectopic expression of ATF3 antagonized TLR-stimulated IL-12p40 activation in a reporter assay. In vivo, CpG-oligodeoxynucleotide, a TLR9 agonist, given i.p. to ATF3-KO mice resulted in enhanced cytokine production from splenocytes. Furthermore, while ATF3-KO mice challenged with a sublethal dose of PR8 influenza virus were delayed in body weight recovery in comparison to wild type, the ATF3-KO mice showed higher titers of serum neutralizing Ab against PR8 5 mo postinfection. Thus, ATF3 behaves as a negative regulatory transcription factor in TLR pathways and, accordingly, deficiency in atf3 alters responses to immunological challenges in vivo. ATF3 dysregulation merits further exploration in diseases such as type I diabetes and cancer, where altered innate immunity has been implicated in their pathogenesis.